US Capitol Capsule: SEC backs up whistleblower shields against 'wolves of Wall Street'
This article was originally published in Scrip
The Securities and Exchange Commission (SEC) is using a lawsuit filed by a former employee of German medical products maker Siemens to solidify the agency's interpretation of whistleblower and anti-retaliation protections in rules it put in place in 2011 under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 – insisting workers are protected under the law whether they make reports of fraud violations internally to their employers or to the commission.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.